Agios Pharmaceuticals, Inc. (AGIO)
NASDAQ: AGIO · Real-Time Price · USD
28.00
+1.15 (4.28%)
At close: Dec 10, 2025, 4:00 PM EST
28.11
+0.11 (0.39%)
After-hours: Dec 10, 2025, 7:56 PM EST
Agios Pharmaceuticals Analyst Ratings
Total Analysts
9
Consensus Rating
Buy
Price Target
$32.13
Upside
+14.75%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Citigroup | Citigroup | Strong Buy Initiates $38 | Strong Buy | Initiates | $38 | +35.71% | Nov 26, 2025 |
| Truist Securities | Truist Securities | Strong Buy Initiates $32 | Strong Buy | Initiates | $32 | +14.29% | Nov 24, 2025 |
| JP Morgan | JP Morgan | Hold Maintains $37 → $20 | Hold | Maintains | $37 → $20 | -28.57% | Nov 21, 2025 |
| RBC Capital | RBC Capital | Buy → Hold Downgrades $57 → $28 | Buy → Hold | Downgrades | $57 → $28 | n/a | Nov 20, 2025 |
| B of A Securities | B of A Securities | Strong Buy Maintains $54 → $32 | Strong Buy | Maintains | $54 → $32 | +14.29% | Nov 20, 2025 |
| Leerink Partners | Leerink Partners | Hold → Buy Upgrades $40 → $34 | Hold → Buy | Upgrades | $40 → $34 | +21.43% | Nov 20, 2025 |
| Goldman Sachs | Goldman Sachs | Hold Maintains $40 → $25 | Hold | Maintains | $40 → $25 | -10.71% | Nov 20, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $56 → $48 | Strong Buy | Maintains | $56 → $48 | +71.43% | Nov 20, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $56 | Strong Buy | Reiterates | $56 | +100.00% | Sep 4, 2025 |
| Scotiabank | Scotiabank | Buy Maintains $71 → $65 | Buy | Maintains | $71 → $65 | +132.14% | Jul 28, 2025 |
| B of A Securities | B of A Securities | Strong Buy Maintains $52 → $51 | Strong Buy | Maintains | $52 → $51 | +82.14% | Jul 22, 2025 |
| Scotiabank | Scotiabank | Buy Maintains $74 → $71 | Buy | Maintains | $74 → $71 | +153.57% | May 2, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $58 | Strong Buy | Reiterates | $58 | +107.14% | Feb 24, 2025 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates n/a | Buy | Reiterates | n/a | n/a | Dec 18, 2024 |
| RBC Capital | RBC Capital | Buy Maintains $55 → $57 | Buy | Maintains | $55 → $57 | +103.57% | Dec 10, 2024 |
| Scotiabank | Scotiabank | Buy Maintains $53 → $75 | Buy | Maintains | $53 → $75 | +167.86% | Dec 9, 2024 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.